"Your vision will become clear only when you can look into your own heart. . .Who looks outside, dreams; who looks inside, awakes."-Carl Jung T he ontogeny and interrelationships of the epicardium surrounding the heart and the vascular beds and conduction pathways investing it remain fundamental mysteries of cardiovascular development. Although several molecules and discrete signaling events have been identified, we lack a detailed schematic of the relevant molecular genetic cascades. Genetic etiologies for congenital heart defects affecting the epicardium and the coronary vasculature have yet to be defined. Successful clinical manipulation of stem cells from a variety of sources in order to recreate blood vessels and conduction tissues in the diseased adult heart would be greatly enhanced by the discovery of a Rosetta stone to decode the key biochemical events and their interactions that comprise such embryonic cardiovascular processes.
T he ontogeny and interrelationships of the epicardium surrounding the heart and the vascular beds and conduction pathways investing it remain fundamental mysteries of cardiovascular development. Although several molecules and discrete signaling events have been identified, we lack a detailed schematic of the relevant molecular genetic cascades. Genetic etiologies for congenital heart defects affecting the epicardium and the coronary vasculature have yet to be defined. Successful clinical manipulation of stem cells from a variety of sources in order to recreate blood vessels and conduction tissues in the diseased adult heart would be greatly enhanced by the discovery of a Rosetta stone to decode the key biochemical events and their interactions that comprise such embryonic cardiovascular processes.
In order to define molecular regulation of coronary vasculogenesis and Purkinje fiber development in the heart, investigators have largely relied on chick and mouse models of cardiogenesis. These animal models have led them to look outside the primitive heart tube for the earliest events that initiate the establishment of these tissues. Such studies have highlighted the contribution of the proepicardial organ (PEO). The PEO (Figure) is an outgrowth of a cluster of extracardiac mesothelial cells on the dorsal body wall adjacent to the heart tube's atrioventricular canal. Cells from the PEO are the precursors for several lineages within the heart including epicardial epithelial cells, myocardial connective tissue cells, coronary vascular smooth muscle cells, and coronary endothelial cells. 1 Moreover, communication between the progeny of PEO cells and cardiomyocytes provides instructions for the differentiation of Purkinje fibers.
Several morphological activities are involved in the embryonic evolution of PEO cells. Cells within the PEO proliferate and then migrate out of the organ to travel over the myocardial surface of the looping heart tube. Villous projections of PEO cells extend over the posterior part of the ventricles and the atrioventricular sulcus. These migrating PEO cells differentiate into a static epithelium that comprises the primitive epicardium. The epicardial layer covers the embryonic myocardium up to the border between the myocardial and mesenchymal regions of the outflow tract. 2 Epicardial cells synthesize a dense layer of extracellular matrix that resides between them and the myocardium. Ultimately, a subpopulation of epithelial cells migrate out of the epicardium into the subepicardial space, and these migrating epicardial cells undergo an epithelial-to-mesenchymal transformation (EMT). The resultant mesenchymal cells invade the actively proliferating myocardium and give rise to cardiac fibroblasts and coronary vasculature. A subgroup of these cells interact further with the myocardial cells and influence myocyte differentiation into Purkinje cells.
EMT is a critical developmental switch that occurs in several organs. The transcription factor WT-1 contributes to this process, and knockout of WT-1 in the mouse leads to deficiencies in EMT and congenital defects in the urogenital system, adrenal gland, and heart. The hearts of WT-1 knockout mice lack epicardium and coronary vessels. 3 Vascular cell adhesion molecule (VCAM-1) 4 and ␣ 4 integrin 5 knockout mice exhibit similar cardiac defects. Several signaling mechanisms have been shown to modify EMT in the heart. For instance, Morabito et al 6 demonstrated in chick cells that fibroblast growth factor (FGF) isoforms, eg, 1, 2, and 7 (and to a lesser degree epidermal growth factor [EGF] and vascular endothelial growth factor [VEGF]) promote EMT of epicardial derived cells (EPDCs), whereas all transforming growth factor-␤ (TGF-␤) isoforms inhibit it. Thus, a balance between myocardial generation of FGF isoforms and of TGF-␤ isoforms may finely regulate EPDC differentiation. A FOG-2/ GATA4-dependent pathway is also critical for coronary vasculogenesis. Knockout of FOG-2 disrupts formation of the coronary vasculature in the mouse, 7-9 and the relevant compartment (ie, myocardial versus proepicardial) primarily affected by this genetic defect remains unclear.
Because of the architecture of the PEO, avian models have been particularly tractable to direct investigation of proepicardial and EPDC development. In contrast to rat and mouse embryos, in which the PEO exists as a diffuse extension of the septum transversum, the chick and quail PEO exists as a free structure able to be manipulated in ovo or easily microdissected and isolated for in vitro studies without fear of potential contamination by non-PEO cells. Yet, establishment of efficient experimental systems for the study of the mammalian PEO and EPDCs remained an important, unattained goal. In an effort to devise a model of mammalian EPDC differentiation, Eid et al 10 In this issue of Circulation Research, Wada and colleagues 11 demonstrate that EMCs, in fact, can mimic at least some components of epicardial differentiation and coronary vasculogenesis. They show that EMCs retain their ability to produce mesenchyme in response to specific growth factors and are able to generate smooth muscle cells. EMCs form an organized epithelium in culture and express proteins (Ecadherin, ␤-catenin) associated with adherens junctions as well as proteins (ZO-1) associated with tight junctions. Bves, an epicardial cell marker described by the same laboratory, is also expressed by EMCs and colocalizes with E-cadherin. Several genes (WT-1, Tbx18, connexin-43, and cytokeratins) whose expression patterns are enriched in epicardium-albeit expressed in other tissues as well-are expressed by EMCs. In the presence of serum-containing medium supplemented with EGF or bFGF, individual cells developed an elongated fibroblast-like contour and lost contact with the epithelial monolayer. Simultaneous disruption of adherens junctions indicated by redistribution of E-cadherin was also observed. Wada et al 11 propose that these events represent an in vitro correlate of EMT in vivo. Importantly, expression of ␣-smooth muscle actin, calponin, and ␣-smooth muscle tropomyosin mRNA in a subpopulation of mesenchyme-like cells suggested that at least some EMCs retained the capacity to differentiate along a smooth muscle lineage. Thus, Wada et al 11 propose that EMCs may provide an easily manipulated in vitro model of EPDC differentiation and coronary vasculogenesis.
These investigators have set the stage for further mechanistic analyses; their work shows that the EMC line can be an invaluable tool for investigators interested in cardiac and vascular development. Certainly, biochemical signaling events triggered in the EMT of EMCs will be elucidated in future studies. The task ahead, though, will include delineating the limitations of the EMC line in modeling events both upstream and downstream from epicardial development.
What characteristics of proepicardial cells are retained by this cell line that already exhibits features of an organized epithelium? Can studies of EMCs shed light on PEO development, expansion, and dispersion that are required for formation of the epicardial layer? As we consider events in organogenesis that follow creation of the epicardial layer, the detailed characterization of the EMC line by Wada et al 11 hints at other unresolved issues. Less than 5% of EMCs retain the ability to differentiate along a smooth muscle lineage, and functional competence of these cells needs to be demonstrated. To date, conditions have not been defined that drive EMC differentiation into endothelial cells, and it remains unknown whether the cell line retains this capacity. Investigators will need to characterize both molecular and physiological markers to distinguish among EMC subpopulations that may be analogous to specialization of EPDCs in vivo. Definition of such profiles will foster efforts to utilize EMCs to unravel biochemical and genetic cascades that trigger epithelial commitment, vascular cell differentiation, and Purkinje fiber induction. Furthermore, dynamic models of EMC function and movement may be devised that will shed light on epicardial cell motility that, in vivo, places EPDCs in apposition with myocardial cells and sets the stage for transformations required for coronary vascular and Purkinje fiber development.
Future investigation of EMCs and other EPDC models may also expand our definition of this cell population. To date, Schematic representation of formation of the epicardium and its derivatives in the embryonic chick. Illustrated are a HamburgerHamilton (HH) stage 18 embryo (asterisk indicates the heart) as well as hearts from HH stage 24 and 29 embryos. The HH stage 29 embryonic heart is illustrated both as a grow image as well as a cross section (plane indicated by dashed line). Gray ovals represent PEO and EPDCs. As described in the text in detail, mesothelial cells migrate out of the PEO and attach to the tubular heart in the region of the atrioventricular sulcus at approximately HH stage 18. A sheet of these epithelial cells then spreads over the naked myocardial surface (HH stage 24) up to the limit of the outflow tract (depicted at HH stage 29) to form the epicardium (represented by gray shading). Through a process of EMT and myocardial invasion by a subpopulation of epicardial cells, EPDCs are established that ultimately give rise to the coronary vascular cells.
studies have considered EPDCs and cardiomyocytes as distinct lineages whose interactions have important developmental consequences. However, evolving data from van den Hoff and colleagues 12 suggest that, at least in vitro, epicardial cells may also be able to differentiate along a cardiomyocyte lineage as well as the vascular path considered by Wada et al. 11 Whether such differentiation occurs in vivo during cardiogenesis is unknown. Taken together, though, current research highlights the extraordinary plasticity of proepicardial and epicardial cells. As we map out the intersecting molecular genetic pathways that regulate their differentiation, we may ultimately find these populations a rich source of progenitor cells to be clinically manipulated in order to regenerate a wide array of impaired structures and functions in the ailing heart.
